Navigation Links
New Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: Resource4thePeople Reports Important Hearing Is Scheduled in Fresenius Multidistrict Litigation
Date:8/16/2013

San Diego, CA (PRWEB) August 16, 2013

http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html

Resource4thePeople today announced a key update for consumers about lawsuits alleging that Fresenius NaturaLyte and GranuFlo kidney dialysis products caused life-threatening heart problems for patients.

The federal judge who has been selected to coordinate consolidated federal lawsuits* involving these allegations against the manufacturer, Fresenius Medical Care, has scheduled an important hearing in which he will meet with lawyers for plaintiffs and defendants, according to the court file.

"The judge has asked the attorneys from both sides in the case to meet and discuss the progress of the litigation and how the cases should proceed," said Resource4thePeople.

"This meeting is called a status conference and will be one of several such hearings in which the public will learn details about these NaturaLyte and GranuFlo dialysis lawsuits as they move through the court system."

Resource4thePeople will continue to provide updates about the progress of these consolidated lawsuits and others that are filed across the country involving allegations of life-threatening heart problems from the use of these dialysis products.

"We are also announcing in response to inquiries from consumers who are not involved in this litigation but may have suffered similar alleged heart problems that our national network of attorneys will continue to offer free consultations and accept cases as this litigation progresses," said Resource4thePeople.

The status conference has been scheduled for Aug. 30, 2013 by Judge Douglas P. Woodlock at the Joseph Moakley Courthouse in Boston, Mass. in the U.S. District Court for M
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. d’Oliveira & Associates Releases Webpage With Current Information on Fresenius Lawsuits
3. Inside Job: Medical Negligence Lawyers at Console & Hollawell Comment on Risks to Dialysis Patients and Impending Legal Action Over Fresenius Controversy
4. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
5. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
6. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
7. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
8. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
9. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
10. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
11. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... common type of lung cancer, researchers have uncovered mutations ... forming tumors. The new knowledge may expand treatments for ... already are available or are in clinical trials. , ... The Cancer Genome Atlas (TCGA), including researchers at Washington ... School and other institutions, studied tumors from 230 patients ...
(Date:7/9/2014)... Center paint a relatively optimistic picture of women,s chances ... spread to the chest wall or skin, but not ... regardless of size and whether they have involved lymph ... called "locally advanced" tumors, suggesting that they are a ... Locally advanced breast cancers of this and other types ...
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... and subjective, the human brain turns them into ... different senses, situations and even people, reports a ... , "We discovered that fine-grained patterns of neural ... the brain associated with emotional processing, act as ... feeling," says Anderson, associate professor of human development ...
(Date:7/9/2014)... been a sharp increase in the number of cancer ... online, interactive service that allows patients to view laboratory ... appointments, and renew prescriptions. , Over a six-year period, ... each year increased five-fold, while the number of total ... a study by Dr. David Gerber , Associate ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3
... the Public Health Grid (PHGrid) technology during the 2009 ... and disease-control agencies when the next emergent disease appears, ... Journal of Grid and Utility Computing . Terry ... Control and Prevention, in Atlanta, Georgia, working with informatics ...
... is an EU-funded research project that develops objective ... Alzheimer,s disease. Diagnosis requires a holistic view of ... as, clinical tests, imaging and blood samples. ... to develop an objective indicator to diagnose Alzheimer,s ...
... June 14 (HealthDay News) -- A mist inhaler with the ... of death among people with chronic obstructive pulmonary disease (COPD), ... soluble form of Spiriva (tiotropium) is approved in 55 countries, ... the powdered form of Spiriva is commonly used to treat ...
... (HealthDay News) -- Patients with early-stage chronic kidney disease are ... a certain hormone, a new study says. Endocrine hormone ... known that levels of FGF-23 increase as kidney function declines ... increased risk of death in patients with kidney failure. But ...
... , Preschool children seem to grasp the true concept of ... value of groups of objects greater than three, research at ... that there are three objects doesn,t have to involve counting. ... necessary to determine how many objects there are," said Elizabeth ...
... PHILADELPHIA Scientists at Harvard University have created a ... observation of early stages of ovarian cancer metastasis. ... that are necessary for the force-dependent processes associated with ... cell biology at Harvard University. These findings are ...
Cached Medicine News:Health News:A grid approach to pandemic disease control 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 2Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 3Health News:Several methods for early diagnosis of Alzheimer's disease developed by European scientists 4Health News:COPD Drug Via Mist Inhaler Could Raise Death Risk: Study 2Health News:Hormone Linked to Death Risk in Those With Early Kidney Disease 2Health News:Learning to count not as easy as 1, 2, 3 2
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Reportlinker.com announces that a new ... its catalogue: Retinal ... Assessment and Market Forecasts to 2017 ... Retinal Vein Occlusion (RVO) ...
... Pharmaceutical Group (NYSE: SCR ) ("Simcere" or ... development, manufacturing, and marketing of branded and proprietary pharmaceuticals ... of shareholders (the "Meeting") will be held on Thursday, ... meeting will be held in No.699-18, Xuanwu Avenue, Xuanwu ...
Cached Medicine Technology:Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 10Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
Inquire...
EL-RF/3 is for measurement of IgM, IgG, IgA RF with high specificity for rheumatoid arthritis....
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: